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CHAPTER 5

IMMUNODEFICIEN CY
DISEASES
AND TUMOR
IMMUNOBIOLOGY
RENE J. DUQ.UESNOY
PETER ABRAMOFF

INTRODUCTION

Basic progress toward an improved understanding of the relation of structure to function of
cella, tiaauee, and organs of the lymphoid sys~m
has taught us about the significance of the Immune apparatus in the pathogenesis of many
di8ea8e procesaes. The classic definition of immunity u being an exemption from disease has
traditionally been related to resistance to infection. Until the turn of the century, the immune
ayttem wu considered to have evolved as a homeoetatic mechanism specifically directed
qainat. infectious agents. It is now recognized
that the immune system participates in many
proceuee of tiuue ~ury elicited by hypersensitivity reactions against a great variety of innocuoua sut.tancea. These immunologicalJy mediated hypenenaitivity reactions of tissue injury
are divided into four major categories: (1) The immediate-type of hypersensitivity reactions mediated by the humoral immune system. (2) The
delayed-type of hypersensitivity reactions which
are manifestations of cellular immunity. (3) The
immune ClOIIlplex diaeasea which result from the
depoaitioa ol circulating aoluble antigen-antibody complexes in the walla of blood vessels and
the glomeruli (4) Autoallergic disorders which
may oocur u a consequence of immunologic reactivity again8t the host's own tissue components.
Theae hypeneoaitivity reactions will be disCUlled in greater length in Chapters 17 and 18.
This chapter deala with the immunopathologic
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mechanisms which underlie certain
normali·
ties of the lymphoid system. We will d • uss those
primary immunodeficiency di sorde~~ due to;
developmental defect of.the lymph OI~ . ...ystem to
well as the immunodeficiency sta tes St ~ o ndary
various diseases.
lfunc·
In the section on tumor immun ol og~ ma ' lh
tion of immunologic processes in patl~nts WI f
malignant disea se will be analyzed 1 terms 0
the surveillance function of the lymplund system
of maJignant growth.
IMMUNODEFICIENCY DISEASES
Development of the Lymphoid System

The hematopoietic system develop:-; from h~.m~
topoietic stem cells residing at d iffe rent l o~a ·~he
during ontogenesis; these locations a re 10 (i tal
primitive blood islets of the yolk sac, the ~e.lll
liver and finally in the bone marrow These 5 the
cells 'can proliferate and diffe rentiate ~lon~on~
hematopoie tic pathways of th e e'?-thrOid, boid
cytic, granulocytic, megakaryocytic. or lymP
systems.
. d stem
In the lymphoid system, t he lympho• hocyte
cells may differentiate to form two lymp d"'
~·
populations: the T lymphocytes, w h'1 ~h are
rnpbo1
pendent upon the thymus, and the
~efi ned
cytes, which are dependent upon an u.n fluentt
bursa equivalent (Fig. 5-l). U nder the 10 f the
of the inductive microenviron ments 0
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THYMUS SYSTEM DEVELOPMENT
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BURSAL SYSTEM DEVELOPMENT
..... 1-1 Two-component concept of the lymphoid system. Lymphoid stem cells may proliferate and differ-

11111111 under Influences of the thymu s or a bursa equivalent to give rise to populations ofT and 8 lymphocytes.
IIIPICihety. (Courtesy of Dr. Robert A. Good, Director o f Sloan-Kettering Institute, New York.)

.,_.cortex and medulla, the prethymic lym. . . ltem cells proliferate and differentiate into

'r ~ (T cells). The lymphocytes which

lllide iD the thymus and which have di fferent
.... ~lymphoid deve lopment are called thy~ It ia not certain whether differentiation
~into aT cell takes place within the
ti-...... before emigration or in the peripheral
Recent exper iments with mice indicate
.... .-tam medullary thymocytes have properlbailar to peripheral T lymphocytes. Fur:;;i&~ that subpopulations of T lympho-

:S ,~ ~~lo;~~nt~ l~e:;:~. ~~~e i;:

---·l•'llcll! function.
. U::::ogenic
.
stimulation , certain T cells
..., ll!llll.;--~ and differentiate to become sensi..... eeUe. These sensitized T cells can be ac,._ bJ antigen to become "killer" lympho11bicb produce soluble factors called
and give rise to the so-called amplilflt,em of cellular immunity. T cells have
ta~ to interact synergistically with
~ the unmune response of mice and a
. . . ,~of other species, bu~ not in rna~.
-....... v....,bocyt.es may express ImmunologiC
·~

1!111iif

fl I
are found in the deep cortical
~ph nodes, the periarteriolar
lllleniC foUicles, the diffused lymphoid

lliiiiatt

tissue of the gastrointestinal tract, the thoracic
duel Jymph, and the circulating blood.
ln the chicken, the organ respons ible for the
differentiation of lymphoid stem cells into B lymphocytes (B cells) is the bursa of Fabricius. It has
yet to be identified in the mammalian species.
The appendix, Peyer's patches, and gut-associated lymphoid tissue as well as tonsils, bone
marrow, and even skin have been implica ted as
the mammalian bursa equivalent; however, these
postulates lack sufficient experimental evidence.
There are two categories of B cells: the nonsecreting and t he secreting B cells. B cells of the
first group ar e capable of synth esizing antibody
but a re not specialized for a ntibody secretion in
large amounts. These cells carry immunoglobulin
receptors for both light. and heavy chains and, in
mice, also have receptors for C3. They can be
found in the far cortical areas of lymph nodes, the
perifoiJicular zones of the ma lpighiao corpuscles
of the spleen, and the circulating blood.
Upon interaction with a ntigen , nonsecretiog B
cells can transform into secreting B lymphocytes
or plasma cells. These cells are specialized for
production and secretion of antibody. They can be
found in the medullary cords of lymph nodes, in
the red pulp of the spleen , in the lamina propria
of the gastrointestinal tract and secretory glands,
in the interstitial tissue of the bone marrow, and,
occasionally, in the peripheral blood and lymph.
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The two-component concept of the lymphoid
system implies that there are two basic syndromes of immunodeficiency: one, a deficiency of
humoral immunity as a consequence of an abnormality of the B cell system, and the other, a defect
of the T cell system of cellular immunity. Patients with immunodeficiency diseases manifest
parts of each syndrome, depending upon the type
and extent of their deficiency. Careful diagnostic
evaluation of both BandT cell systems is mandatory in the proper management and treatment of
the disease in these patients.
Evaluation of th e T Cell Syste m

Generally , a T cell deficiency is indicated with
increased susceptibility to infection by fungi,
viruses, atypical acid-fast organisms, and some of
the so-called lower-grade pathogens. Causative
organisms include Candida albicans, vaccinia
and mumps viruses, Mycoplasma, Staphylococcus, and Pneumocystis carinii. On the other
hand, fewer problems are encountered with highgrade encapsulated pathogens, such as Pneumococcus, Haemophilus, Streptococcus, and Meningococcus.
Pneumocystis carinii deserves special attention, since it frequently causes severe pulmonary
disease in patients with immunodeficiency. In
these patients, pneumocystis pneumonia shows
characteristic accumulations of foamy, pinkstaining exudates containing many pneumocystis
organisms (Fig. 5-2A and B ). This protozoan
produces disease in patients with B a nd T cell
deficiencies and has also caused plasma cell pneumonia epidemics in neonates and premature and
debilitated infants in central Europe. The diagnosis of pneumocystis infections in patients with
immunodeficiency disease is hampered by the absence of any demonstrable specific immune response. Demonstration of specific antibodies in
close relatives of the patient may provide an indication of pneumocystis infection; otherwise, a
lung biopsy is a better diagnostic measurement.
Early pneumocystis infection can be effectively
treated with pentamidine isethionate.
The laboratory evaluation of the T cell system
in patients with suspected immunodeficiency is
given in Table 5-1. An effective test for the analysis of the T cell population is a quantitation of
the responsiveness of peripheral blood lymphocytes or lymph node cells to blastogenic stimulation with phytohemagglutinin (PHA). The capability to develop delayed allergic reactions may
be analyzed by the ability to develop contact
allergy after stimulation with dinitrochlorobenzene (DNCB). Skin tests for delayed hypersensitivity to ubiquitous antigens such as mumps,
Candida, Trichophyton, tu'berculin, histoplasmin,
and streptokinase-streptodornase may be of little
value in young children who have had little op-

portunity to develop cell-mediated i m rn une responses to these antigens. However . negative
skin tests to Candida antigens in chiltl ·n suffer·
ing from infection with this fungus -~ay have
diagnostic usefulness. Tests for the .tbility ro
reject allogeneic skin grafts are no l o; ,~er commonly used.
Morphologic analysis of the numbe of small
lymphocytes in peripheral blood and i the deep
cortical areas of biopsied lymph node~ nay provide some quantitation of the TcelJ sys r m. Since
T lymphocytes do not have immunog 1{,bulin receptors on their cell su1'face, mem ·• a ne im·
munofluorescence methods with fiuor :.cent Ia·
beled antiglobulin antibodies sho u lJ give 8
higher ratio of positively staining lymJ •ocytes in
T cell deficient patients than in norm u persons.
Although T cells in mice have specific lllembrane
markers (e.g., theta and TL antig· ts}, such
markers have not been demonstrate d (1 0 human
T cells.
Several tests for lymphokine prod u~· ion have
been developed which are of potential usefulness
in the evaluation of the amplification :.;ystem of
cellular immunity. In particular, tht: ca pillary
test for migration inhibitory factor h ab become 8
routine procedure in many laboratorie".
Evaluation of the 8 Cell System

A deficiency of the B cell system is ge uerally in·
dicated with frequent occurrences of infection
causing pneumonia, otitis media, conJunctivitis,
meningitis, and sepsis. Causative microorga·
nisms incJude Pneumococcus, Streptococcus,
Haemophilus, Meningococcus, Pscudorno~
aerugirwsa, hepatitis virus, and P neumocysiJS
carinii. These patients experience fewe r problems
with handling of Staphylococcus, most e nterobac·
teria, mycobacteria, fungi, and viruses.
Most laboratory tests for evaluation of the B
cell system are carried out on the p rod ucts o~ B
lymphocytes, i.e., the antibodies and un·
munoglobulins (Table 5-2). Electrophoretic an~
immunoelectroph oretic analyses of serum an
secretions provide qualitative informa t ion a~ut
the presence or absence of the various 1Jll'
munoglobulins, as well as the prese nce of b~
mogeneous immunoglobulin populations seen 10
monoclonal gammopathies.
A variety of immunologic methods are c~r·
rently available for determining immunoglob~
levels. Most commonly used is the radial iJII·
munoditfusion technique by which the test~
is allowed to diffuse in a layer of agar gel contaJll'
ing antiserum specific to one of the j []llJl~
globulins. The concentration of each irnm~OO'
globulin is determined by comparing th~ di~
eter of the precipitin ring with that gtven
an immunoglobulin standard solution of delin
concentration. When special precautions are

J

IMMUNODEFICIENCY DISEASES AND TUMOR IMMUNOBJOLOCY

•

•

~~

...._,Of

127

--·

.

Pneumocystis pneumonia in an agammaglobulinemic patient. A, Eosinophilic accumulations in
~on. B, Pneumocystis carlnii organisms in pul monary exudate. (Courtesy of Dr. Robert A. Good,
oan-Ketterlng Institute, New York.)
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TABLE 5-1

SCI ENTIFI C FOUNDATIONS
LABORATORY EVALUATION OF
T CELL FUNCTION

1. Microbiological studies, history of infections.
2. Quantitation of PHA-ioduced lymphocyte
blastogenesis.
3. Skin t.est.s for delayed hypersensitivity to ubiquitous
antigens.
4. Development of contact a llergy to DNCB.
5. Blood lymphocyte count.
6. Allogeneic skin graft rejection.
7. Histologic analysis of lymphocyte populations in
thymus-dependent areas of lymph nodes.
8. Immunoglobulin receptors on lymphocytes.
9. Amplification of cellular immunity, MJF test.

taken to ensure that the immunoglobulins in the
standards and the sera are not split or aggregated, the radial immunodiffusion method can
be used to measure, with some accw·acy, the
level s of IgG, IgM, l gA, and JgD. Serum lgE
levels are measured with the radioimmunoassay
method. The normal values for each of these immunoglobulins are given on p. 101. Caution
should be given in the evaluation of immunoglobulin levels in adult serum, s ince they
may vary greatly from individua l to individual
and a re related to age, sex, environment, and
racial background. No threshold for values can be
set for the diagnosis of immunoglobulin deficiencies unless associated with clinical symptom s.
Rel iable measurements cannot be made with
such proteins as low molecular weight IgM and
secretory IgA unless a standard immunoglobulin
is available in the same form.
Special attention should be given to analysis of
the su bclasses of immunoglobulins. Using appropriate antisera, the levels of immunoglobulin
subclasses are measured by radial immunodiffusion or direct hemagglutination-inhibition
tests. The a pproximate percentages in American
Caucasians of norma] serum lgG a re lgG1, 66 per
cent; l gG2 , 23 per cent; IgGa, 7 per cent; and IgG~,
4 per cent. The importance of determining immunoglobulin subclasses has been demonstrated
in certain patients with normal total I gG serum
leve ls, but lacking one of the IgG subclasses, and
showing great susceptibility to pneumococcaJ and
other high-grade, extracellular, pyogenic pathogens, similar to patients with generalized B cell
immunodeficiency diseases.
Humoral immune function of the B ceU system
can be evaluated by tests for existing antibody to
a ntigen to which man is commonly exposed or by
humoral antibody assays following active immunization. Antibodies to ubiquitous antigens
include type A a nd B isohemagglutinins a nd antibodies to infectious agents, e.g., antistreptolysin 0 , antiviral antibodies and agglutinins
of typhoid, paratyphoid, brucella, diphtheria,

tetanus, Candida, and Staphylocc IS. The
a ntigens used for active immunizati 1 should
be proteins as well as polysaccharide:-. uantita·
tion of antibody responses may be • ried out
following injection of poliovirus vacl 'S, diphtheria, tetanus, and pertussis tr •td, and
pneumococcal or meningococcal pol ' tccharide
antigens. The use of live vaccines !e.•• Bacillus
ofCalmette-Guerin (BCG) or attenuat• I viruses)
should always be avoided. Howe·. ·r, more
than j ust the total amount of an udy produced should be considered. The tduction,
logarithmic, plateau. and decline ph •s of an·
tibody production should be measun• ' henever
possible. The normal maturation of 1 , tmmune
response (from predominantly IgM
predomi·
nantly lgGl ought to be followed.
Absence of low serum levels of one c more immunoglobulins may have three poss t' causes:
(1) absence or decreased numbers of B lis in the
cit·cula lion and lymphoid tissue, (2l defect in
immunoglobulin secretion by B cell!-. nd {3) an
increased rate of immunoglobulin
tnbolism.
The following tests need t.o be can·iec u t to distinguish between these possibilit ies. 1 •termina·
tion of lymphocyte membrane imm JOfluorescence with fluorescent antibodies . unst the
various immunoglobulins can be used ' analyze
the B cell population in the circulatio IS welJas
in the lymph nodes. In addition, one c· •t look for
the presence of germinal centers and pi •Hma cells
in lymph nodes. The evalualiOJ of immunoglobulin catabolism can be detc r mined by
measurement of the rate of disappeat tnce of ra·
dioactivity from the circulation foliO\\ mg injec·
t ion of ra dio-labeled immunoglobulin ....
A complete evaluation of the B c- II syste!D
should include analysis of the ampli ft, ttion systems belonging lo t he various types of ntibodies
For instance, analysis of complemen fi xing anti bodies can be carried out to detect t h ..;e types rl.

TABLE 5-2

LABORATORY EVALUATION Of
8 CELL FUNCTION

1. Microbiolog ical studies, history of inft·•·ttons.
2. Electrophoresis and immunoeleclrophm••sis
of serum.
3. Concentration of immunoglobulin clo"'t'' and subclasses in serum and secretions by r ad1al 1DllliUJlit
diffusion.
4. Tests for antibodies to ubiquitous anliJ!t'OS.
5. Quantitation of humoral immune respon~e.
6. Immunoglobulin receptors on lymphoc' tes by me~
brane immunofluorescence.
7. Histology of lymph node biopsies, J{crminal center
formation.
B. Analysis of immunoglobulin cataboli!lm.
o1
9. Amplification of humoral immunity ('ompleme
system.
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laG utibody

which are unable t.o activate the

CliiiiiJ)Iement system. Evaluation of the comple-

IIIIDteyatem may also be necessary to determine
tbelevelsof complementcomponents and some of
tbe bameoetatic control mechanisms of the complement system, s uch as Cl esterase inhjbitor.
, . , , Immunodeficiencies
Primary immunodeficiency results f1·om a fail-

ue to produce the effectors of the immune re.,._, i.e., antibodies and sensitized lymphoeyta Excluded from thls definition are the
hJpen:atabolic states and disorders in the amplibtion systems, such as the complement deficieDeiel. Secondary immunodeficiencies may
occur in patients with a variety of diseases.
'l1le variability of immunologic findings
..-ta a major difficulty in classification of the
priiDiry immunodeficiencies. Often neither etioJap: u functional or structural considerations.
tabD alone or together are satisfactory for ade..._dasaifi.cation of immunodeficiency diseases
Ia 111111. Well-eharacterized diseases associated
with primary immunodeficiency are listed in
Tillie 5-3. However, the majority of patients with
iluaaDodeficiency cannot be unequivocally clasliWud are ther~:.fore grouped under the headil(ohariable immunodeficiency. The probable
.... at which various primary im.....s.&c:iency diseases interfere with normal
~development are shown in Figure 5-3.
OaiJ. rew will be selected for discussion.
Patients with infantile, sex-linked agamlllllobalinemia (Bruton's agammaglobulinemia)

TABLE 5-3 SELECTED PRIMARY
IMMUNODEFICIENCY DISEASes·
Suggested
Cellular Defect

Dleotder

8

T

Cells

Cells

...... • ·linked agam..:£:'"11Demia (Bruton's)

+

......_~unoglobul in

~llgA)

~~.

~li•YDdrome)

~~ficiency

+
+
+
+

:::-~ syndrome

+
+
+

+

'=" ~11Dode6ciency

+

+

...,....;' leo..-y with

-

Stem
Cells

+

I
.,
.
•11.:~claaai6ca:tion is given in Fudenberg, H..
- - . : . , 47:927, 1971.

+

C+)

129

have an immunodeficiency exclusively involving
the B cell system while the functions attribuLable to the T cell system appear to be intact.
Concentration of each of the immunoglobulins
in serum or secretions is very low or a bsent,
and humoral antibody responses are absent
even to repeated injections of potent antigens.
Histologic sturues show that lymph nodes
and spleen of these patients lack germinaJ
centers, and that plasma cells are absent ft·om
lymph nodes, spleen, bone marrow, and connective tissue including the lamina propria (Figs. 54A and B, 5-5A and 8 ). The tonsils have poorly
developed lymphoid elements which lack follicular components (Fig. 5-6A and 8 ). By contrast,
these patients have normal or nearly normal
levels of circulating lymphocytes, nor mal
numbers of lymphocytes in the thymus-dependent regions of lymph nodes and spleen, and a
normal thymus. Membrane immunofluorescence
methods show absence of immunoglobulin receptors on these lymphocytes.
These patients usually have recurrent bacterial infections which begin during the second six
months oflife. They show extraordinary susceptibility to infection with certain extracellular
pyogenic pathogens like Pneumococcus, Streptococcus, a nd Haemophilus, but. infections with
other organisms like Staphylococcus and Pseudomonas occur only occasionaJiy. Many patients develop pneumocystis infections. They suffer t·epea tedly from acute episodes of otitis, sinusitis, skin
infection , conjunctivitis, a nd pulmonary disease.
Such patients are also prone to septicemia and
meningitis. In striking contrast, these patients
can resist infections by many other microorganisms including viruses, fungi, and most enterobacteria, even when they appear to produce
little or no antibody t.o these microorganisms.
They seem unable to resist infection with hepatitis virus, and s uch infections us ually cause either massive liver destruction or chronic active
hepatitis with steady progression to complete destruction of the liver. Patients with sex-linked
agammaglobulinemia are prone to develop connective tissue diseases such as arthritis, der matomyositis, and diffuse vasculitis. F urthermore,
they often develop malignant conrutions, especially in the lymphoreticular and gastrointestinal tissues.
Certain selective immunoglobulin deficiencies
have been described which seem to be associated
with defective development of a single immunoglobulin class. One of the most common
primary immunodeficiency ruseases is the isolated (or selective) deficiency of lgA which affects
1 out of 700 persons. Most patients are clinkaUy
asymptomatic but some may have recurrent gastrointestinal infections and a s pruelike syndrome. The incidence of rheumatoid arthritis,
lupus erythematosus. tenosynovitis, a nd other

SCIENTIFIC FOUNDATIONS
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Figure 5-3 Possible sites of defect in the development of the lymphoid system of patients with var ous types ol
primary immunodeficiency. (1) lmm u nodeficiency with generalized hematopoietic hypoplasia, reticular dysgenesis. (2) Autosomal recessive combined immunodeficiency. (3) Sex-linked and sporadic types of immunodeficiency.
(4) Thymic hypoplasia (DiGeorge). (5) Ataxia-telangiectasia (6) Infantile sex-linked agammaglobulinemia. (1)
Selective immunoglobulin deficiency (lgA), transient hypogammaglobulinemia of infancy. (8) Thymus dysplasia
with normal immunoglobulins (Nezelof).

mesenchymal diseases is higher in patients with
selective TgA deficiency. A number of patients
with low levels of IgA produce anti-lgA antibodies which lead to decreased survival rate of
serum IgA. Blood products containing IgA given
to these individuals may result in anaphylactic
reactions. Selective lgA deficiency causes low
levels of lgA in serum as well as in secretions.
The two subclasses, A, and A~, are usually reduced in equal proportions. However, in certain
patients, low serum lgA levels are accompanied
by normal concentrations of secretory IgA. The
reverse situation may be prese nt in other patients with IgA deficiency.
Selective lgE immunoglobulin deficiencies
have been described in children and are associated with frequent episodes of respiratory infections developing into a progressive sinopulmonary disease.
Severe immunodeficiency disease of the
thymus-dependent system is present in patients
with thymic hypoplasia (DiGeorge syndrome}. In
these patients there is a congenital arrest in the
development of the thymus and parathyroids
from the epithelial anlage derived from the ill
and N pharyngeal pouches. Such infants w:ith

hypocalcemic tetany at birth are una ble to sur·
vi ve because they lack the capacity to develop the
T cell system and to express cell-med1. 1ted imJl!U·
nity. Circulatin g lymphocyte counts ure usu~Iy
near normal at birth but soon decline tn a signtfi·
cantly low level. These patients fa il to expre~
any of the functions of cellular im munity B.?
have a high susceptibility to fungal and viral.1°'
fections. By contrast, their levels of Jill'
munoglobulin are normal, plasma cells a:e
present in normal n umbers in the lymphoid us·
sues in bone marrow, and the thymus-indepen·
dent regions of lymph nodes and spleen are ~~
preserved. The thymus-dependent, deep cortJ bs
areas of lymph nodes and periarteriolar sheal
of splenic follicles are depleted of lympboc~f
(Fig. 5- 4C). Infections usually begin early in ~
and may be caused by fungi, viruses. atYP1 d
acid-fast organisms, low-grade and high·gt,8 I~.~
encapsulated bacteria, and Pneumocystis cannaf.
Severe combined immunodeficienc.) disease ·
fects both B and T cell systems. The aut.osorosl
recessive variant of this alymphocytic agalll'
maglobulinemia bas been called Swiss t)'J*
agammaglobulinemia. These patients have ~
vere cellular defects in the development of h

IMMUNODEFICIENCY DISEASES AND T U MOR IMMU NOBIOLOGY
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Lymph node histology In primary immunodeficiency. A, Stimulated lymph node of a normal 11- . Child. Well-developed germinal centers and abundance of plasma cells. The cortical and deep cortical
. , . . densely populated by lymphocytes. 8 , Lymph node from a boy with infantile sex-linked recessive
-::wlnemla 5 days after secondary antigenic stimulation. Absence of cortical germinal centers and
.....,
dense populations of small lymphocytes in the deep cortical regions. a n d lymphocyte depletion in
._;.~ymph node from a patient with thymic hypoplasia. The thymus-dependent deep cortical regions are
.... ._ ~I lymphocytes. Lymphoid follicles. germinal centers. and plasma cells are present. 0, Lymph
- - ~ld with autosomal recessive combined Immunodeficiency disease. Severe depletion ot lympho~ot~ cells ~ccompanied by histiocytOSIS and stro m al hyperplasia. (Courtesy of Dr. Robert A. G ood,
-Kettertng Institute, New York.)
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Figure 5-5 Histology of spleen in primary immunodeficiency. A. Spleen of a child who died of c?nge~
heart disease at 3 months of age. Note the normal dense lymphoid cellu larity of the malpighian ~oii 1Cies loP"
several germinal centers. B, Spleen from child with sex-linked agammaglobulinemia. Note th e p nmit1ve de~es
ment of lymphoid follicles and absence of germinal centers and plasma cells. C , Severe depletion of lymph r1es1
and plasma cells in spleen from patient with autosomal recessive combined immunodeficiency disease. (Cou
of Dr. Robert A. Good. Director of Sloan-Kettering Institute, New York.)
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. : : ; 1-t A, Normal tonsillar tissue with

abundanc~
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of lymphoid elements. 8 , Tonstl from a pattent w tth

.._YIIIt.~·Hnked agammaglobulinemia. (Courtesy of Dr. Robert A. Good. Dtrector of Sloan-Kettering lnstttu te,
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moral as well as cell-mediated immunity as a
consequence of a lymphoid stem cell defect. Very
young infants are affected by this disease and suffer recun-ent infections with a great variety of
microorganisms. They generally succumb during
the first year of life to low-grade, opportunistic
pathogens such as Pseudomonas, Staphylococcus,
the common enterobacteria, Pneumocystis
carinii, and Candida albicans. If exposed to
meas les virus, they may die of a characteristic
giant cell pneumonia (Hecht's pneumonia); they
do not show the characteristic measles rash. Also,
progressive, generalized vaccinia will occur after
dermal smallpox vaccination.
Serum levels of all immunoglobulin classes are
either absent or ext1·emely low. The thymus is
hypoplastic and lacks lymphoid cel ls and Hassail's corpuscles (Fig. 5-7). These patients have
sever e lymphopenia and an absence or marked
deficiency of lymphocytes in the thymus-dependent as well as the thymus-independent regions
of peripheral lymphoid tissues (Fig. 5-4C and D ).
In addition to the Swiss type of agammaglobulinemia, a large number of patients have
lymphopenic immunodeficiency syndrome which
varies greatly in the clinical and laboratory manifestations. Some of these patients are clearly of
sex-linked recessive inheritance, others seem to
be inherited as autosomal r-ecessive tr-aits, and
still others have thus far not revealed any hereditary patterns. Laboratory evaluation of both T
and B cell systems show variability of immunodeficiency. Some patients with these forms
of combined immunodeficiency possess nearly
normal amounts of IgM, little IgG, and no IgA.

Different degrees of defective devcl··. ment of peripheral lymphoid organs and t h:-. n .~ have also
been observed.
Immunodeficiency of the B cell ystem, and
especially of the T cell system, i~ <!• .-uuntered .in
ataxia-telangiectasia (Louis-Bat syndrome).
These patients develop a progrel:'~i e cerebellar
ataxia which usually begins durin£; .he first few
years of life. They often have rec.;·-rent pulmo.
nary infections and develop promin• nt telangiectases in the sclerae, the skin or th eyelids, the
ear lobes, the neck, and the poplil< t1 and antecubital spaces. These patients h.:,·e variable
degrees of deficiency of the cell ..ediated im·
mune responses. In some instam ~ they show
deficient antibody production to ·~rtain rela·
tively weak im:munogens. A la1 ~·· percentage
have low levels of IgA and Igr 1s a consequence of decreased rate of syn ,1 :esis of the
immunoglobulins. Several pat.iP•· · have an
increased rate of IgA catabolism ht•cause of the
presence of anti-IgA antibodies. 1 tstologically,
the thymus-dependent regions of the peripheral
lymphoid tissue show a depletior • f small lym·
phocytes. The thymus is small , ''"tcks Hassall's
corpuscles and is poorly organizeo ;nto a co~
and medulla (Fig. 5-8). Female t·hildren ~V_Jtb
ataxia-telangiectasia frequently ~how ovanan
dysgenesis. The etiology of this au wsomal recessive disease is not well understQ,.t[, but may be
due to a neuroendocrine abnormhl ty. These pa·
tients have a relatively h.igh su -· e ptibility to
malignant disease, in particu lflr. lymphosar·
coma, reticulum cell sarcoma, or reticuloen·
dotheliosis.

Figure 5-7 The hypoplastic tilt
mus lacking lympho•d elements and
Hassalrs corpuscle 1s a salient feature of autosomal recessive combined immunodeficiency dise;:
(Courtesy of Dr. Robert A. ~ e
Director of Sloan-KettennQlnst•tul
New York.)
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,._. 1-1 Thymus In ata)(la~~~~ng~~et~~la.

Severe lymphoid depilliOn In bOth cortex and medulla.
Hlllll't corpuscles are absent
fCourt11Y of Dr. Robert A. Good.
1J111C111r of Sloan-Kettering Institute•

._York.)

fte Wiakott-Aldrich syndrome is a sex-linked
.._cbaracterized by a central thrombopenia,
-.and marked susceptibility t.o many infec.... Patiente with this syndrome lack Lhe nor.a ilohemagglutinins and hemolysins and fa il
ltJI'OIIace antibodies to polysaccharide a ntigens.
., Cllllllrut, the humoral a n tibody response 1.o
....... IUc:h as tetanus toxoid is normal. In
.... petiente a progressive d eficiency of cell....._. immunity develops. Like the patients
_. l&aia-telangiectasia, a high mcidence of
~ar malignant conditions is found.
, _ ..upant conditions may rapidly become
d4t¥wd and seem to have great propensity to
._.. the central nervous system. [ l appears
Ill tile buic immunologic defect in these pa. _ ia..,avee the afferent limb of the immune
...... and perhaps resides primarily in the
~processing of antigen.
.:::. &a with a benign spindle cell tumor of the
been described as having hypogam-.1 bave
I
;:..h»mia,
antibody deficiency syndrome,
t1 cellular immunity, and often an ab: -,tl tllliDophils. As with other hypogam41
,.(
nemic patients, they are prone t.o detr aotlmtia and other a u toallergic and
'-iillrs_. diaeases.
.... !P'aP of variable immunode fici ency dis.. ilchidea many syndromes which a re not
~ Included in this group are cases
~ dueified as "congenital" nonsexWipOhdic hypogammaglobulinemia, pri~mmaglobulinemia" of both childhood
..... I I lite, and "acquired" primary hypogamI

1~.

Treatment of Immunodeficiency

Considerable improvement is achieved in pa·
t ients with B cell deficiency by replacemenllherapy with gamma globulins. Special precaulions
s h ould be taken lo avo1d infection by hepatitis
virus which frequently causes lethal li ver dibease
in these patients. Some patien ts with thy mic
h y poplasia h ave been su ccessfully treated with
fetal thymus transplants. Although these tra ns·
plants came from hist.oincompatible donors, Lhey
were able to recon stitu te T cell function for a cons iderable time. Combined immunodeficiency disease can be corrected by transplanting a source of
ly mphoid stem cells, usu ally the bone marrow .
The development of grafl.-versus-hos l disease is a
serious complication, because the bone marrow
gives rise Lo a population of immu nocompetent
Lymphmd cells which make an immune response
against Lhe
hist.oincompatible
~nd
immunologically incompetent host. Ide ntity across
the HL-A histocompatibi lity locus is generally
required for the s uccessful acceptance of these
bone marrow transplants.
Disorders of Immunoglobulin Metabolism

T h ese may occur secondarily to a variety .or
p athophysiologic mechan isms. As has been diSc u ssed above, hypogammaglobulinemia may be
due to a primary immunodeficiency of the B
ly mphocyte system affecting one or more classes
of immunoglobuli ns. Alternatively, h ypoga.mmaglobulinemia may be secondary to excess1ve
loss of immunoglobulins into the uri n ary or gastrointestinal tracts. Finally, abnormal im-
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munoglobulin levels may be secondary to disorders of endogenous immunoglobulin catabolic
pathways. Accelerated catabolism may affect one
or more immunoglobulin classes.
Accelerated catabolism of IgG has been observed in patients with myotonic dystrophy. This
autosomal dominant disorder is characterized by
myotonia, muscle wasting, premature baldness
and testicular atrophy, cataracts, and electrocardiographic abnormaUties. The serum levels and
metabolism of albumin, IgM, IgA, IgD, and IgE
are normal. In contrast, serum levels of IgG are
markedly reduced as the result of an accelerated
catabolism.
An increased rate of catabolism oflgA has been
observed in patients with iso.lated IgA deficiency
or ataxia-telangiectasia, when they produce antiIgA antibodies.
Alternatively, generalized hypercatabolism of
many serum proteins, including immunoglobulins, is often present in patients with
Wiskott-Aidrich syndrome or with familial hypercatabolic hypoproteinemia. Elevated urinary
or serum levels of immunoglobulin light chains
are observed in patients with tubular proteinuria
or uremia when the normal site of catabolism of
these molecules, the proximal convoluted tubules, is damaged.

Disorders of the Complement System

A variety of genetically determined abnormalities of the complement system have been described. These can be classified as (1) defects in
inhibitors which result in the spontaneous consumption of complement components, (2) synthesis of defective complement molecules, and (3) absence of a complement component.
Hereditary angioedema is caused by a defective
synthesis of Cl esterase inhibitor. In normal persons, Cl esterase inhibitor blocks the activity of
Cls and is therefore capable of suppressing the
progression of the complement sequence beyond
Cl. This enzyme also inhibi ts the activity of certain enzymes active in the clotting system, including the Hageman factor , plasmin, and prekallikrein. Patients with hereditary angioedema
suffer from episodic triggerings of the complement system and develop severe angioedematous
reactions in various tissues, particularly those of
the upper respiratory tract. It is unclear why
these patients have episodic disease, but trauma,
menstruation, and infections may precipitate
clinical crises. This disease may be observed at
any age but usually first manifests itself during
late adolescence or early adult life. The recurrent
attacks of edema are mostly confined to skin, gastrointestinal tract, and respiratory mucosa. The
edema is nonpitting and nonpruritic. The episodes last for about 48 to 72 hours. The involve-

ment of the larynx is most sen • ' .md many pa·
tients may die from suffocat
Hereditary
angioedema exists in two geneti
nants.ln one
type no Cl esterase is produced .. r I in the other
the protein is made but is not I' tiona!.
Patients with a defect in C3 ,. , .11>olism as the
result of an abnormal activity ''
proactivator
suffer fi·om fi·equent recurrent
ogenic infoo·
tions. Familial C5 dysfunction h , - •ee n described
in patients with Leiner's syncLc e who suffer
from generalized seborrheic der. · lliis, intracta·
ble severe diarrhe a , recunent J,,
and systemic
bacterial infections usually of g 1 1- negative eli·
ology, and a marked wasiin... ,d dystrophy.
Deficient opsonic act ivity of t.bt· lient's serum
with yeast cells is the diagnoslic "boratory finding in this disease.
Autosomal recessive C2 de ft• · '·v is usually
not associated with any clin c•. disease. Al·
though the sera of these paticn• 1re extremely
defective in he molytic activit) . 1.1 my biological
functions of the complement S\ tem, like im·
munoadher ence and facilitalion ' t phagocytosis,
seem unimpaired. It appears th o~ t 2 deficient in·
dividuals ha ve an unusua lly h\~ 1 incidence of
hypersensitivity disease.
Patients with the autosomal r<·•'!!SSive form or
combined immunodeficiency di.,t>ase have ex·
tremely low serum levels of C l l'. S ince Clq ~as
an electrophoretic mobility of a g uu ma globuh~.
it is particularly interesting t h.•t this protem
should be defective in patients lu Kmg both Band
T lymphoid cells. In contrast, pal il'nts with set·
linked, recessive combined im n1t'nodeficiency as
well as the various form!; ol hypoga!llDlJI·
globu1inemia show only sl igl·t to moderate
reduction of Clq levels.
Experimental strains of mice und rabbits hal'e
been described which lack C5 an d C6, respt!C'
tively. Low serum levels of complc•ment canal~
be observed secondary to a vatil'ty of disease5>
particularly in immune complex di::;easessucha!
acute glomerulonephritis, syslem1c lupus e~
matosus, and poststr eptococca l glomerulonep ·
tis.
Secondary
Immunodeficiency Diseases

. · ha'ses'l!
Although pr imary immunodeficlencle~
received considerable attention. these :d~lll'
are rather uncommon. ln contrast, depre COil'
mune function occurs quite frequently as 8 ·aJif
sequence of various disease states, espec~
those that cause disturbances in general me dan.'
lism and which induce stress. These seco~ ~
immunodeficiencies are frequenlly .observ 1*:
certain infections, maligna nt cond•t•~ns 1 J
cially of the lymphoid system I, excess•veh1raP>·
proteins or cells from the body. dr_u~ t illl'
debilitating diseases, and a ging. Clln~caJ Y·

0:
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mUDOCieficiency is first indicated by more
trequent and persisting infections with one spec:i6c microorganism or a var iety of microorgan.._ Secondary immunodeficiencies may affect
both humoral and cellular immune systems, and
may operate at the induction (afferent. limb) or
~ion (efferent limb) of immunity. The
JDitbods of evaluation of humoral and cellular
imJDilDe function in patients with suspected secOIIIIaryimmunodeficiency are listed in Tables 5-l

111116-2.
c.tain infections may lead to dec1·eased imfunction. For example, secondary immuadeficiency is usually present in infants with
CIJIII8Dital rubella syndrome. Infection with rubella virus is contracted during the second and
tiUrd 010nth of gestation. These patients have a
CllldiDuing active viral infection from birth up to
18 IIIODths of age and produce antiviral antilladiea, primarily of the IgM type. Increased
.am lgM levels are frequently accompanied by
-wly reduced IgG concentrations; ocCIIiaaally there is a generalized hypogam~inemia. During active rubeUa infection,
PldpberaJ blood lymphocytes may fail to undergo
~lutinin-induced blastogenesis. lnllr:liaaa with measles (rubeola) virus frequently
...._ a temporary loss of delayed hypersensitlti&J. Tuberculin-positive patients may tempo..n, loee their ability to express a delayed alllrliC reaction to tuberculin protein during a
...... infection. Lymphocytes from these pallllllare unable to respond with blastogenesis to
...... although their responsiveness to phyto~~~in or other mi'togens is unaltered.
~ infected by Mycoplasma also have
"bed ability to r espond to antigenic and
-....me stimulation.
~ immunoproliferative diseases are accomby a secondary immunodeficiency state.
-.....&!proliferation may affect the B and T
systems. Best known are the secreta.;;_ .U tumors, which include multiple mye~ ·~~trom's macroglobulinemia, and
... ~ disease. These disorders have often
the monoclonal gammopathies beplas~a cell tumors produce excessive
....... of an ammunoglobulin of sh arply res... 11101ecular heterogeneity. These parapro. . .-.y be of any one of the immunoglobulin
-.,.
UJd may have the same basic molecular
~- aa their ~ormal counterparts. An excep._.,•~protem of heavy chain disease which
)ICil't.ion of the Fd fragment of the heavy
~ p. 100). Since numerous myeloma pro~ bee~ found to have antibody specificity
.....:,~tige~, it is currently believed that
~ PJ'Ote1ns are antibodies of restricted
- . - ; llpecificity. Light chains of either
.....,~types may be produced in. excess
and may circulate as free dimers
IIIUD8

;:;-nme
:...theee
..a
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of homogeneous light chains. Because of t heir
small size they are rapidly excreted in the urine
(Bence Jones proteins) .
Patients with multiple myeloma often suffer
from recurrent infections with Pneumococcus and
other highly pathogenic bacteria. They have no
unusual susceptibility to infections with staphylococci, enterobacteria, or fungi. Severe deficiency of the B cell immune system can be demonstrated
by the low levels of serum
immunoglobulin and seems to be a result of decreased synthesis of normal immunoglobulin
molecules. Antibody synthesis against exogenously administered antigen is markedly delldent. lo contrast, cellular immune function is
grossly normal.
Patients with Waldenstrom's macroglobulinemia have excessively high serum levels of a high
molecular weight protein which has the chemical
and immunochemical characteristics of lgM. Because of the high intrinsic viscosity of IgM protein, these patients have increased viscosity of
the serum. which leads to sl uggish blood flow,
thrombosis, central nervous system disturbances,
and bleeding. Most commonly affected are the
skin, nasal mucosa, and gastrointestinal tract.
Sluggish blood flow of the retinal vessels may
eventually cause thrombosis of retinal veins and
blindness. Frequently, the patient's red cells,
granulocytes, and particularly platelets may be
coated with macroglobulins, which results in impaired survival and function of these elements.
Lymphadenopathy and hepatosplenomegaly are
salient. features. Hyperproduction of IgM macroglobulin is often accompanied by decreased synthesis of other immunoglobulins. Many patients
produce detectable amounts of monomeric, low
molecular weight macroglobuljns (7S IgM). Approximately 10 per cent have demonstrable
Bence Jones proteinurea.
The recent elucidation of the structure of the
immunoglobulins (see p. 101) and the detailed
characterization of the proteins in serum and
urine of patients with proliferative disorders of
plasma cells and lymphocytes have led to a better
understanding of the biosynthetic alterations accompanying these disorders. These diseases are
now frequently classified on lhe basis of the products of the neoplastic cells. Multiple myeloma is
defined by the type of immunoglobulins produced
(G, A, D, and E myeloma}, and the biosyntbetic
processes in myeloma and macroglobulinemia
can be either t..be balanced synthesis of heavy and
light chains, resulting in homogeneous serum immunoglobulin, or the unbalanced synthesis manifested by the presence of light and occasiona11y
heavy chains as an additional, or at times, the
sole detectable product. In addition, the recognition of several new disorders of immunoglobulin
synthesis has resulted in the identification of a
number of new syndromes. Best described among
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these are the group of heavy chain diseases which
represent examples of abnormal immunoglobulin
synthesis and assembly. Three types of heavy
chain diseases corresponding to the heavy chains
of IgG (gamma), lgA (alpha), and lgM (mu) a re
now recognized. Gamma chain disease is most
frequently seen in the middle aged and elderly. A
rather characteristic clinical picture which resembles a malignant lymphoma rather than multiple myeloma includes lymphadenopathy and
hepatosplenomegaly. Involvement of the nodes of
Waldeyer's ring resulting in palatal edema is
particularly striking. Almost all patients suffer
from frequent episodes of infection. Anemia, leukopenia, eosinophilia, and hyperuricemia are
common but are relatively nonspecific laboratory
findings. Definitive diagnosis of gamma chain
disease can only be made by immunochemical
analysis of serum and urine proteins. Characteristically, there is a broad peak with a mobility of
a beta globulin present in both serum and urine.
Amino acid sequence analysis of gamma chain
disease proteins has demonstrated deletion of
most of the Fd fragment as a consequence of loss
of interchain disulfide bridges. Alpha chain disease has been found in patients with malignant
lymphoma involving the small intestine and is
usually associated with severe malabsorption. A
few cases of mu . chain disease have been descri~d in patients with chronic lymphocytic leukerrua.
Pa~ien~ with Hodgkin's disease develop a progressive Immunodeficiency of the cellular immune system while humoral immune function
appears essentially normal. Both the afferent and
efferent limbs ofT cell-mediated cellular immun~~ ar~ deficient. Although patients with Bodg~m s dis~ase have a normal resistance to infections W1th Pneumococcus, Haemophilus, and
Str_eptococcus, they are susceptible to tuberculosis and fungal infections.
Patients with chronic lymphocytic leukemia
develop deficiencies of both the T and B cell im~une systems: Both immune systems are essentially normal m acute lymphocytic leukemia In
later_ ~bases of these lymphoreticular malignant
~ndibons, ~pparently as a consequence of continuous anttcanc:er chemotherapy, defective host
defense mech~msms a llow recurrent infections
to become an lllllllense problem.
. The lymphoreticular malignant condit"
lik~ the lymphocytic leukemias, the Jympho~::·
retlculum cell sarcomas, and Hodgkin's disea '
. se,
have thus far been classified on
. the basts of
morphologic and clini 1 b
.h
ca o servatJons. However
Wit r~spect to our rapidly expanding know led ~
of the 1rnmunelympboid system ·t · d ·
g
1 ify h
.
, I 1s a vtsable to
c ass. t ese proliferative disorders accord'
functiOnal characteristics of B d T 1 mg to
cytes Expe ·
.
an
Ymphochr .. l . ~men~al evidence indicates that
omc ymp ocytlc leukemia is probably a non-

secreting B cell leukemia and t't-': n forms or
ma ligna nt lymphoma are T cell 1 • 11 ,.,.
Patients wit h nephrotic syndt • • have low
serum le vels of a lbumin and ~·• · 1 globulin
because the excessive amounb ol
-e proteins
are lost in the urine. ConscqUL'llll these pa·
tients are very susceptible lo in · • •ns by encapsulated microorganisms a~; ,.
as gram.
negative bacteria. Nephrotic pu 1 L~ respond
well to immunogenic stimuli nil' pccific an·
tibody is rapidly lost in the urirh"
tl! mosl af.
fected immunoglobulin is lgG. wi t~ I• 1•~ .11 1 and the
beta and alpha globuli ns of the '''
Pment sys·
tern are norma l. This is also lhl
in classic
lipoid nephrosis of children. In ro
-t. patients
with acute glomerulonephritis fill I • t tain forms
of chronic glomerulonephritis nut
\ lose protein in the urine but a lso depo:-11
mune com·
plexes and compleme nt in their
1 •evs. These
patients may have complemt•
d;ficiencies
because of an excessive rate of ut 1 • tlion. Some
patients with hypocomplemenh'
forms of
chronic rena l disease may have u
reased rate
of synthesis of complement con 1 tcnls. especially C3. These patients have ad
1ished abil·
ity to de velop infla mmatory resp
~.
Protein losses from t he intestu .ract during
certain acute and chronic disea~ , ,f the bowel
may lead to bypogammaglobuli nl
In intesti·
nal lymphangiectasia, both seru • Proteins and
lymphocytes a r e lost in t he stool Hl'h patients
have low immunoglobulin Jevek I. mphopenia.
and deficient immune function o1 ') 11 h B and T
cell systems.
Patients who have sustained n · r bum inju·
ries develop immunodefi ciencies. A • .1nsient by·
pogammaglobulinemia may occr• during the
first wee k because of losses th' 111 :h the burn
lesions. Increased synthesis of 1nu unoglobulins
overcompensates for these losse"
week lat.er.
Lymphocyte depletion occurs a" n•sult of destruction of lymphocytes under th nfluenceof_a
stress-induced incr ease of adn·rh ·orlicosteroJd
production. The markedly decrea:-• r resistance of
burn patients to infections is mu111h due to t~el
relative inability of their neu , phils to kJi
phagocytosed bacteria.

TUMOR IMMUNOLOGY
Tumor-Associated AnUgens (TumorSpecific Antigens)

The majority of tumors, incl ud111g those in:
duced by chemical carcinogen:- , nd viruses,~
~ell as spontaneously arising lumCirs. carry 3~
tigens w~ich elicit immune responsi'S ~n the hOSts
Tumors 1_nd~~d by chemical m· plnstcaJ ag~al
express mdtv1dually distinct an ll!cns so 1 .10
cross-immunJzaLion is rarefy pn~s1hle even
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tumon of similar morphology induced by the
. - carcinogen. In contrast, virus-induced
tumon contain cross-reacting antigens showing
~related specificities. Immunization against
0111 tumor may lead to protection against other
tuiiiOI'I induced by the same virus. This difflnace in the specificities of antigens associated
with tumors induced by chemical carcinogens
IJIIIICIIICOgellic viruses has provided a method for
clelermining the etiology of spon taneous tumors.
SiJiceeeveral virus-induced tumot·s have r ecenlly
beeubown to have individually speci fic an ligens
belidel the common antigens coded for by the
Yinll, this distinction is less clear and definition
Gltbe antigenic tumor specHicities does not proQiecoodusive evidence of its etiology. In additioD,IeVeral chemical carcinogen-induced t.umors
Dalate the production of antibodies which
a.-react with antigens associated with certain

.....

'l'bere are two ml\)or categories of tumor-as.ut.edantigens in virus-induced neopl asms: (1)
the 9irus-specific a ntigens and (2) the newly
"-1 antigens, i.e., the antigens Lhat were not
..-t in the normal cells before neoplastic
lrlllbmation, or on the virions. Antigens
~to the latter category may a r ise as (al
~ of a specific interaction of the viral
. . . . with the host genome, (b) a specific un.....q of normal or preexisting (embryonic?J
Cllllprodw:ts, or (c) as a consequence of derepresliiiiGlintracellular type-C RNA viruses.
'1\e virus-specific a ntigens may be structural
~tsofthe virion or virus-coated products
~ by the n eoplastic cells. Although
~ IDtigena are frequently demonstr able in
- tirua-induced neoplasms, Lhey are rarely
- i t tumors induced by DNA viruses. In leuke:::.iadw:ed by RNA viruses, cell surface anlllay be shared with those of the virion.
·~-- ma~ure at the cell membrane by budad the vtrus particles wbkh are continu-~ by the leukemic cells receive an outer
.,.. the cell membrane.
'-ar-~peeific antigens in DNA virus-induced
~~~ ~ .not identical with the antjgens of
~ vtnon and are present even when in~ beYU'WI production by the transformed cells
Illite ~monstrated. Since these antigens
tpecifically to the inducing virus, their
and permanence suggest that viruses
part of their genetic information in
"---~p~astic transformation. In view of
~-.-ctlvtty of cells of different types and
t.& the tumors in different species, it is likely
~Dew antigens on the su rface of DNA
... UCed tumor ceUs are determined by t.he
a,~·. On the other hand, tumors induced
............VIrUses do n ot cross-react., even when
......
are morphologically similar and are
il tbe same species. Exceptions to these

C:::

•.a:..least
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rules for cross-reactivity of chemical- or virus-induced neoplasms may occur when the transformed cells express new antigens related to derepression of certain bost genomes or of intracellul a r virogenes.
Derepression of cell genome-coated products
occurs in certain types of tumors giving rise to
t u mor-associated antilgens which cross-react with
antigens found in embryonal tissue but not in
adult host tissue. Most frequently described are
the carcinoembryonic antigen of carcinom a of the
colon a nd the alpha fetoprotein associated with
hepatic malignant disease in man. The relation
between the appearance of these embryonal antigens and neoplastic transformalion is not clear,
since carcinoembryonic antigen has recently
been found in colonic and other gastrointestinal
t issue in patients with various non-neoplastic
disorders. Several experimentally induct-d tumors also express emlbryonal tissue antigens.
Recent. studies support the concept that vertebrates cont.ain t.he genetic information for producing type-C RNA tumor virus i n an unexpressed form in their somatic cells as well as in
their germ cells. The viral oncogene theory proposes that the endogenous virogenes (the genes
for production of type-C viruses) and Lhe oncogenes (that portion of the virogeoe responsible
for transforming a norm al cell into a neoplastic
cell) are maintajned in an unexpressed form by
repressors in normal cells. Various agen ts, including radiation, chemical carcinogens, and exogenously added viruses, may transform cells by
"switching on" the e ndogenous oncogene information. It is under these conditions that the
major i ntemal antigen of type-C virus, the group
s pecific or gs antigen can be detected i n tumorous
tissue.
One approach t.o studying Lhe etiology of
h u man malignant. disease has been the detection
of immunologic cross-reactivity in a variety of
human tumors. Since all tumors induced by the
same virus contain common tumor -associated antigens, while neoplasms induced by different
viruses or by nonviral carcinogens usually lack a
common antigenicity, one would anticipate a
common viral etiology from neoplasms possessing
common tumor-associated antigens. However,
immunologic cross-reacti vity between t.umors
can be due to the presence of embryon ic and gs
antigens or antigens indu ced by virus infection of
tumor cells. Patterns of cross--reactivity have
been demonstrated between antigens associated
with a variety of tumors. Various human cancers
origi nating in the same organs appear to share
antigens recognized as foreign by the immune
system of the patient. while being undetectable in
normal cells of the aame organ. Certain human
tumors s hare common antigens not found on
other tumors. They include neuroblastoma, mammary carcinoma, endometrial cancer, colonic car-
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cinoma, bladder tumors, and malignant melanomas. These observations suggest a viral etiology
for the majority of human neoplasms, provided
that one postulates that there is a large array of
viruses, each of which is associated with neoplasms of a certain origin. This could be the case
for RNA viruses, which are us ually specific for
the type of tumor and organ affected. Unfortunately, ther·e are no data to support the hypothesis that these human tumors are induced by
tumor viruses. On the other hand, there is evidence that common antigens detected in Burkitt's
lymphoma and nasopharyngeal tumor are associated with the presence of Epstein-Barr (EB)
herpes type virus in t hese neoplasms. The question to be resolved for these neoplasms is whether
they carry EB virus as an etiologic agent or as a
passenger virus.
Demonstration of Tumor Immunity

It is generally accepted that both cell-mediated
and humoral immune response play a major role
in host-tumor relationships. Histologic evidence
of tumor immuruty is indicated by the infiltration
of several types of tumor by mononuclear lymphoid cells, which is frequently accompanied by
increased cellularity of the regional lymph nodes.
For instance, in malignant melanoma, this appearance is most frequently found around primary tumors and early tumor·s. The lymphocellular response usually decreases as time elapses
and the tumor grows. Increased proliferation of
mononuclear cells in t he regional lymph nodes
and infi ltration of lymphocytes and plasma cells
around the periphery of the tumor have often
been associated with a favorable prognosis of pat ie nts with various types of malignant disease
(e.g., mammary carcinoma, gastric carcinoma,
malignant melanoma, testicular seminoma, and
urinary bladder tumor).
Several in-vitro tests have been developed to
analyze humoral and cellular immunity to tumor
cells. H umoral antibodies can be demonstrated
by tests for cytotoxicity, membrane immunofluorescence, and mhed hemadsorption and
immune adherence. Cytotoxicity tests determine
tumor-specific antibodies which, in the presence
of complement, exert a cytolytic effect on tumor
cells. Although these cytotoxicity tests may be
useful in determining humoral immunity to lymphoma and leukemia cells, they rarely work for
sarcomas and carcinomas. Cell surface antigens
are demonstrable by membrane immunofluorescence in Burkitt's lymphoma and nasopharyngeal carcinoma in which cross-reacting
antigens associated with the EB virus can be detected.
Cell-mediated immunity to malignant disease
has been demonstrated by use of in-vitro assays
with tumors from experimental animals as well

as in man. These tests are based or •e fact lhal
tumor-specific immune lymphoc'
UJX>D interaction with tumor cells, can h1 ·tivated to
produce solu ble factors, lymphoktn which par·
ticipate in the amplification "-'
m of cell·
mediated immunity and which m \ cad to destruction of the tumor cell. T he n.: . ,,. evidence
for cell-mediated immune retH 1'•Jils against
human tumors has come from stud
performed
with the colony-inhibition techniqn l'umor cells
are first grown in vitro and are ll , CXJX>Sed to
tumor-specific immune lymphocytt' rhe inhibi·
tory effect. of these lymphocytes ~~ -cssed by a
reduction in the number of t01
,'O)orues as
compared t.o the effect with nonitP ne lymph&
cytes.
The fit·st human tumor to be
Ired by the
CoJony-inhibit.ion technique WaS II rob)astoma.
It. was found that peripheral blood vmphocytes
from patients with such tumors in i111 1!Led colony
for·mation of neuroblastoma cells. \' hct.her they
were of auLochthonous or allogent•l ur·igin. Nor·
mal skin fibroblasts from tumor do ·l'S were not
inhibited. Lymphocytes from • tients with
tumors other than neuroblaston • and from
donors not having cancer did not nhibit these
neuroblastoma cells. Thus, the I~
1ocyte effect
was specific and could not be attn I • ·d to immu·
nity to normal alloantigens. The,., >hservatioDS
also implied that neuroblastomas I t• a common
tumor-associated antigen.
Similar results have been oblattwd with the
colony-inhibition test in a large VHI II'IY of hum~
malignant conditions (Table 5-4 1 In many rn·

TABLE 5-4 ANTIGENIC CROSS REACTIVITY
BETWEEN TUMORS OF THE SAME TYPE

Tumor Type

Number of Pa tient·Tumot
Cell Co mbinations
P ositive Per Number of
Com b/nat1ons Tested'

-------

--------------------------Melanoma
-tl 41
Colon cancer
Breast cancer
Lung cancer
Sarcoma
Endometrial cancer
Ovarian cancer
Testicular tumor
Squamous cell cancer
Kidney cancer
Wilms' tumor
Parotid tumor
Total

:L!i/31
I ~/ 14

fi'6
.!3

23
.!5
" 10
- "l
l I

112
I I

(ll:l !19 t87'fl

• Tumor patient lymphocytes were (l',tcd on l~
tumor cells derived from different donor' ull hav.np Or
same type of neoplasm. [nformati(j n n1urtcs~ 0
K. E. Hellstrom.
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l&aJIC88, the speciiic in hibition of colony forma-

tioa by lymphocytes from patients with a certain
type of tumor has provided evidence of antigenic
~reactivi ty withi n (but not between) groups
fltumors of the same morphology.
Several neoplasms in experimenLal animals
le., ., Shope papilloma in rabbits and Moloney
virua-induced sarcomas in micel and man (e.g.,
aeuroblastoma) undergo spontaneous regression.
Thia was not due to a lteration of cellui8J· immunity to the tumor cells, since lymphocytes from
both persistors (in whom tumors were growing)
llld regressors (in whom the tumors bad recre-dl had the same inhibitory effect on colony
l'arma.tion. On the oth er hand, incubation of the
tumor cell cultures with serum from persisters
abolisbed the tumor-inhibiting effect of both perlilt.or and regressor lymphocytes (Fig. 5-9).
Serum from regressors did not interfere with the
antitumor activity of these lymphocytes.
The serum of tumor-bearing individuals has
afteD been shown to block the activity of tumorlplcific immune lymphocytes in the colonyillbibit.ion technique. This ser um blocking activity has been associated with tumor-specific antibodies or with antig:;m-antibody complexes. Pro-
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vided that these antibodies or complexes have a
si milar effect in vivo as in vitro, the presence of
serum blocking activity would be a powerful
mechanism of escape from a n efficient lymphocyte-mediated immune sur veillance of tumor
growth. Ifthe development of blocking antibodies
plays an important role in enabling tumors to
g row in an immunologically sensitized host, it
should be possible to inhibit tumor growth by
measures that counteract the blocking activity,
either by the prevention of blocking a ntibody formation or by intervention with its action. In this
respect, it was found that in Moloney sarcomas of
mice and other tumor systems a dmixture of regressor serum to persister serum abolishes the
blocking activity of regressor serum, and the
blocking activity of persister serum is not well
understood.
Host-Tumor Relationships and
/mmunosurve/1/ance

From a teleologic standpoint, it is generally accep ted that the lymphoid system may have
evolved in vertebrates for the purpose of seeking
out, recognizing, and destroying malignantly a l-

Control Cultures

+8
+

+tj

or

Penistor
LYftlphocytes

~H

~

Saline
or
Normol
Serum

Persis tor
Se rum

Regressor
Se rum

Regre sso r
l ymphocytes

(;)

Colony-inhibition assay. Lymphocytes from hosts with grow1ng tumors (persisters) and fro m hosts
... ~tumors (regressors) inhibit the in-vitro formation of tumor colonies. Serum from persistors block
1101.....,.; biting effect of both persist or and regressor lymphocytes. In contrast, serum fro m regressors does
...._
this blocking effect and may even have the capability to "unblock" the blocking act ivity of persister
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TABLE 5-5 MALIGNANT CONDITIONS IN PATIENTS WITH IMMUNCC

Primary Disease

Number of
Patients Who
De11e/oped
Malignant
Condition

i'
Types of
Malignant Conditions

Infantile sex-linked
agammaglobulinemia

5

Ataxia-telangiectasia

42

Many

Wiskott-Aldrich syndrome

13

MosUy

Leukemia

of
I•

f.

centage
tlents
., Cancer

I 1 per cenL

II • • 1 ·, per cenl
I t per cent

ly mphoreticular

Common variable immunodeficiency

30+

Severe combined immunodeficiency

3

Many

1

J per cent

11 per cenL

"Observations by Dr. R. A. Good.

tered tissue. This surveillance system may be just
another homeostatic control mechanism throug h
which the host maintains its integrity. Faulty
immunosurveillance is generally a ssociated wi th
increased incidence of malignant disease. D ecreased immune function normally presen t in immature or aging animals or experimentally induced by irradiation, neonatal thymectomy, and
ad.n;Unistration of immunosuppressive drugs or
antilymphocyte serum is often associated with an
~creased susceptibility to malignancy. In additton, m~ch c~icaJ evidence links the lymphoid .
system mextricably with malignant change in
man. Regardless of the nature of the disorder :all
forms of primary immunodeficiency of m an h'ave
~own e~dence of increased susceptibility to ma ~gnant dtSease. For example, patie n ts with a sex~~ recessive Bruton type agammaglobu!femJa are inordinately susceptible to t he
e~opment of leukemia. A high incidence of
~ant ~sease is also found in atax:iaticulDfl~Ja. These diseases are frequently rek ~m ce sarcomas, lymphosarcomas, and le ubut epithelial malignant diseases espe~~ Y 0~ the gastrointe~tinal tract and of other
~rting and m~sencbymal tissu es, have a lso
reported, P atients with the Wiskott-Aldrich
8YDdro me have a hi h fr
disease th
g
equen cy of malignan t
ticuJ~ ~ ~ost co~on form of which is a r eas well~ ~mo; which .often affects the brain
organs, A hi h ~ .Ymph01d an~ bema~poietic
encounteredg . lDCldence of malignant disease is
syndromes (T~le~~\. other inununodeficiency
Conversely mal'
.
system such ~ H tgn~~ d1~ase of the lymphoid
loma, and chro . ~kin s ~1sease, multiple myefest severe rnaffi:c ~mphatic leukemia all manimunity, or both ~cti~ndofh_um~ral or cellulaJ· imdeecnbed in
·. uc ~ficJencies h ave also been
patients With malignan t diseases of

:Ia

·:188•

n on lymphoid organs. Thcs• . wnls respond subn ormally to immuno~eni,·
1 ulation with teta·
n us toxoid, dinitrochlm·, •, · ene rDNCBl, and
tuberculin. For instance 1 1 , ma bility of breast
can cer patients to becon••· !ll•n.silized to DNCB
h as been associaled with , ••I' prognosis. It is
quite likely that the 1m1• 111 defect in these
cancer patients is a co
).tt-..nce of advanced
disease and not ils cau st
The concept of immum 1 ullance shoul~ by
no means be construed , ttu• only mech am~m
ser ving to control nt>u~ 1 1c change.. For I.D·
stance, the role of hormot'•· in the survetiJanceof
e ndocl'ine tissue and t he tumors is well docu·
mented. Contact inh1b1•
nf isolated aberrant
cells provides anotht 1 n.< chanism. o~ . 5~~
veillance. Closely r escrnl>hnt t:~nl~ct.J~~J bJII~ .
is the p henomenon of tllug~·neJc mhlbtti~n,
w hich cells with diffc n.'rL :-.1! uctures on the1rce.1
s urfaces mutually in hib:1 lll'll' growth whe~;
con tact with each other A ,, wly formed neop II>
tic cell may be elimm.. 1 ·d hv the normal ceh·
aroun d it long before it IJ, ,·nn es recognized by.t e
.
f th se nonun·
tmmune system. The :'\t~l r u1ce? e
ainsl
m u nologic mechantsm,.. n .;urvedlance ag
malignancy is difficult I· Jl'scss.
.
pear
Th e combined sun·~tll.111n mechamsm58
/ ant
to be most effective tn tht L'ontrol of ma:Sil-e
change. In spile of thP eout 1nuous and ex. veTY
8
exposure to carcinogeni< 1eents, cance~ .' \l'e
·
L
addJtl0°•
uncom mon tn most 11g-~ gwups. n
type£
probably carry oncnJ!Pntt' vtruses (e.;~plasrns
RNA virusesl wh1ch m:1~ mduce
under certain condJlion..;.
en illl'
Although the 3!-'SOciatiOn be~W~dence o[
munodeficiency and tht mcreased 10~~ IJ)(JSI
m alignant disease ll' I\'(• II documen ~~ irn·
cancer patients have nu l11slory of app~n.••n~
.
.
· · these"...,...,...
m unodefic1ency d1sorders. It IS 10
·c 8 beJ11·
th at. the relation lwhwt•n tm munologt

j
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ticJD aud neoplastic growth is poorly understood.
Severa) mechanisms have been proposed by

which tumors can overcome immunosurvei I lance

bJ the lymphoid system. The escape of neoplastic
powth from immunosurveillance may occur at
the level ofinduction of the immune response (afferent limb) or at the level of expression of i mmuDity (efferent limb).
In the afferent limb of the immune response,

the tumor antigens should be regarded as tumor
immunogens. The structw·e and physiochemical
uture of these immunogens , as well as the
IJIIOUDta present in the tumor and available for
immunogenic stimulation, obviously have great
iD8uence on the outcome of the tumor-specific imJIIIIIIe response.. When a cell undergoes a neoplutic: change, itseems quite likely that sufficient
IIIIOUDta of tumor-specific antigen must be preseat on that cell to stimulate the immune system.
Tberefore, this neoplastic cell wi!J probably
have to undergo a number of divisions before
ldcient quantities of tumor-specific antigens
are present to eHcit an immune response. 1m-.opoic stimulation of the lymphoid system
il probably induced by the antigenic structures
}lllll!llt on tumor cell break-down products,
.ta 18 c:ell membranes, which enter the regional
I,llpb nodes by way of the draining lymphatics.
WileD the immunogenicity of the tumor is low,
•when the tumor has a high cellular proliferatiaa rate, the tumor may outgrow its susceptililitJ to the effects of the immune svstem and
.._ -.pe immune surveillan ce.
·
IDaperimental studies, it has been shown that
llflllareofthe animals to an oncogenic virus or a
Clft:!Dopn will temporarily suppress the im-l'elponse. With reference to the unknown
llialoo of moat human cancers, it is not known
wlledaer this potential suppression of the iml'llponse is relevant to the development of
malignant disease.
~uaologic factors may suppress lhose cells
lacr' most surface immunogenici ly and "se. . ~-~Hs with the least immunogenidty.
. . -~lection may represent a mechan~ch a neoplastic cell with low immUllOi;;;";{ meaks tbxougb" the immunosurveil-

::::a

..!t.

'nae the host.

~ti~ background of the host may also

....._. his ammune system. It bas been demon... ~the quantity as well as the quality of
......._
response is controlled by "immune
..._. ~nes." some of which appear to be as~th transplantation genes. Several in... ~ewe! have o~rved that these operate at
J....a.:.::~ the antagen-reactive thymus-derived
~but others have indicated that an-.....;
ng B cells may also be involved.
.._.. ~that. these genes may be one of
Jilltic
factors affecting a variety of neoautoaUergic diseases. For instance,

:-rue:

143

the resistance of mice to Gross virus leukemogenesis is under the influence of two genes, one of
which is the immune r esponse gene, the other a
histocompatibility gene. ln this respect it is interesting to note that certain types of malignant
disease occur in higher frequency in patients having specific combinations of transplantation antigens. For instance, the presence of HLA-5 antigen is associated with an increased incidence of
Hodgkin's disease.
ll is possible that th e host has developed immunologic tolerance to his tumor, similar to the
chimeric state seen after transplantation of hematopoietic and other tissues, so that rejection
does not occur. Pregnancy represents a comparable balanced immunologic relationship whereby
the graft, the fetus, survives in an immunologically incompatible host, the mother. ln
chimerism. as in the host-tumor relationship, we
appear to be dealing with a complex set of biological problems involving the potentiality for adaptation by the graft or tumor and the host. Our attention in tumor immunology has been focused
on immunologic adaptation by the host. Attent ion must be given to t.he possible contr·ibution of
the tumors in this process .
Even when a host develops a vigorous immune
response against the tumor, i.e., an effective cellul ar immunity which may be accompanied by
humoral cytotoxic antibody formation, t he possibility still exists that the tumor survives in the
host. This situation is prevalenL in many tumor
systems as demonstrated by the presence of
blocking factors which interfere with the antitumor activity of tumor-specific immune lymphocytes in the colony-inhibition technique. These
blocking factors resemble the antibody molecules
responsible for the phenomenon of immuneenhancement. Experimental studies have shown
t hat passive transfer of tumor-specific a ntibodies into a syngeneic host exerts an enhancing effect on the growth of a transplant of thal
tumor. Also, mixing of humoral antibody with
tumor cells in vitro made possible t heir developm ent into tumors under conditions which otherwise precluded such events. Several explanations
have been proposed about. the mechanism of immunoenhancement by humoral antibodies. An
essential component is that such protecti ve action by humoral antibodies is likely to take place
in situations in which the host defense is primarily mediated by immune lymphocytes. One
explanation is that immunoenhancement is active at the efferenL Hmb of lhe immune response.
T h e antigenic determinants on the t umor cell
surface are blocked by antibody so that immune
lymphocytes do not recognize these antigens and
therefore do not attack tumor cells. T h ese humor al antibodies may also prevent tumor antigens from sensitizing lymphocytes or they may
interfere with proliferation or new reactive popu-
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lations of immune lymphocytes. These postulates
for the mechanism of action of enhancing antibodies may also apply to those factors which
block the activity of tumor-immune lymphocytes
in the colony-inhibition assay. However, r ecent
evidence seems to indicate that the blocking factors are circulating complexes between antibody
and tumor-associated antigens.
An important consideration should be gi ven to
.t he role of tumor-associated antigens in the efferent Limb of the host immune response to the
tumor. They can be classified into two groups: (1)
those antigens present on the cell surface that
have been called tumor-rejection antigens, and
(2 ) the soluble antigens localized in the cell cytoplasm and nucleus to which specific immunity
has little effect on tumor growth. The avallabitity
of tumor-rejection antigens to the effector mechanisms of humoral and cellular immunity greatly
influences their efficiency. For instance, tumor
antigens deeply embedded in the cell surface are
inaccessible to antibodies as well as to immune
lymphocytes. Also, the density of tumor-rejection
antigens on the cell surface is rele vant to the effectiveness of certain types of immune responses.
For example, IgG complement-fixing antibody
requires a relatively high density of tumor antigen to induce a cytotoxic effect on the tumor cell
because of the requirement of the close proximity
of at least two IgG molecules on the surface to activate the complement sequence (see Chapter 4).
The same cytotoxic complement-fixing antibody
does not exhibit this effect when the density of
the tumor-rejection antigen is low. In this situation, by combining with the antigens on the
tumor cell, this antibody may interfere with the
effector mechanisms of tumor-specific cellular immunity.
Clinical Applications of Tumor
lmmunobio/ogy

Our rapidly expanding knowledge of tumor immunology has provided a basis for the immunologic approach in the diagnosis and treatment of
malignant disease. Since the demonstration of
tumor-specific antigens in a great variety of
human malignant diseases, many attempts are
underway to isolate and purify these substances.
The development of practical tests for tumor
antigen detection should enhance diagnosis and
permit detection of residual tumor after therapy.
Tumor-specific immunity, both cell-mediated
and humoral, can now be assessed in vitro on an
experimental basis. However , most of the
methods involved are technically difficult and not
practical for routine use.
Evaluation of the general status of the immune
system of the tumor patient can be of prognostic
value. For example, total lymphocyte counts are
low, delayed hypersensitivity reactions to com-

mon antigens are l.ess frequent, ph 1hemagglo·
tinin-induced transformation of 1) .phocytes is
reduced, and susceptibility to set• lttzation to
DNCB is impaired in cancer pali•
who have
extensive and disseminated dif't-' • Unfortu·
nately, these observations are apph·· ·ble to some
tumors but not to others.
Another important application 1 1 tumor immunology is the use ofimmunologi. :.rinciples in
the treatment of cancer. ln most cn.'-· the central
problem of tumor immunotherap) · not that of
inducing the patient to become ; r •tune to his
t umor, but rather to make exis11
immunity
more effective in controlling tum rrowth. lm·
munotherapy must attempt to d ir"'. the interact ion between tumor growth and l ll• or immunity
in favor of the host, e ither by qu.
tative aug·
mentation of immunity or by qu. a tive alt.er·
ation of the immune response so w- l•. expose new
tumor vulnerabilities. The approae. , of augment·
ing tumor-specific cell-mediated i ., ,;une mecha·
nisms or depression of the humor. 1 1mmune response should be considered with so~e
skepticism, since many of thr · nmunolog~c
aspects of the interaction between ho"'t and tumor
are still poorly understood.
.
Attempts to increase cell-medt. ·,·d immumty
by adoptive transfer of allogeneic J""'. kocytes (rom
other individuals who had spont.,.,t•ous regres·
sion or who bad been tumor-immunized has bad
limited success. This may be a Ll .huted to .the
relatively short life span of the hi :-.1 1 \ncompattble
lymphocytes or to a graft-versus-h1 1 reaction .oc·
curring in patients receiving immP •tnsuppressiOD
by their tumor or by chernothera p> On the oth~
hand, adaptive transfer thrOUJ.!H the .use.
t ransfer factor obtained from tumr•r-spec1fic ~~;
mune lymphocytes may be a potl'rttially usefw
approach.
.
Another approach to augment .wm of ac~l'f
tumor immunity is to increase or ,titer the un·
munogenicity of tumor cells. For e\.<Un ple, tUJllOr
cells have been altered chemicalh or enz~s
tically so that they become more immunogelllc.
Painting of skin sensitizers such a~ ONCB on su·
perficial squamous ski n cancers of DNCB-se~SI·
tized patients, has induced selective tumor reJec-10
tion. This method represents a new approach
the control of dermal cancers.
·on
In addition to the specific a ugmentatt
methods mentioned above, nonspecific augm~
tion of tumor immunity appear~ to have Jini·
achieved through immunization with BCG. C P"
cal trials using tbis approach to immunothera ·
of leukemia have been relatively ;;uccessful. ra1
Finally, cautious manipulation ~f the h~~lll
immune response of the cancer paltent !e.g., !~
blocking antibody to unblocking a ntib<>?Yl or~
ministration of unblocking anti botl) wtth tu iJII"
specificity may offer a promisi ng approach to
munot herapy.

IMMUNODEFICIENCY DISEASES AND TUMOR lMMUNOBIOLOGY

145

REFERENCES
_

........IICU

A)euader, J. W., and Good, R. A.: l mmunobiology for Surgeon!!.

Pbit.delpbia, W. B. Saunders Co., 1970.

" - B. (Ed.): Progress in Immuno logy, New Yor k, Academic
"'-. 1971.

Bellanti. J. A.: Immunology. Pbi lade lphta, W B. Saunders Co ..
lf71.
'-'-·B. K., and .Houck, J . C.: lm munopalhology of lnflom..tioa. Amaterdam, Excerpta Medtca. 197J.
Flwdman. 8.: CUnical Immunology. New Yor k, Harper and
... 1971.
Jtilldlef. P. A., and Mueller-Eberhard, II. J . IEds.l: Textbook
allmmUJIOPlllhology. New York, Gru ne and St.rnlt.on, 1969

!IIGwlt. H. Z.: lnftommntion , lmmunlty and Hypersensitivity
New York, Harper and Row, 1971 .
llaMr, M. (Ed.): Immunological Diseases. Boston, LiU.II!
Bron mel Co., 1971.
Wak.aD, B. R.: Atlas of Experi men tal l mmunobiology and
'-11110P8Lhology. New Haven, CDnnecticul, Yale Untvcr·
lily " ' - . 1970.
Ill ICIIIICY DII£ASIES

Alplr, C A.. and Roeen, P. S.: Genetic RBpt!cl.!l of the complc-.& tyllem. Adv. lmmunol., /4:252, 1971.

........ D., and Good, R. A. (Eds . 1: Immunologic Dellciency
..._ In Man. The Nationa l Foundat ion of Birth Defects,
OriPaal Article Series, Vol. IV, No. I, 1968.
a.tia. M. M.: A oompendium of re ported h uman bone marrow
lrllllplant.. Transplantation, 9:571, 1970.
Wit,, R. H.: Reconstitution: grnn.ing of bone ma rrow and
...,._ In Amoe, B.(£~): Progress in Immunology. New
Yft, Academtc Press, 197 L
"-kkia. E. C.: Some protein disorders associated with neo" - o( pluma ceHs and lymphocytes: heavy chain d i.""
111 Amos, B. (Ed.); P ro2J'es& in Immunology. New York ,
Aadeauc ""-· 1971.
.
.......... H., Good, R. A., Goodma n, H. C .. Hilzig. W., Kuolrlllll• H. 0., Roi.tt. 1. M. , Rosen, F. S .. Rowe, D. S .• Seligmonn,
. lllld Sooth!ll, J . R.: Pri mary immunodeficiencies. Report
~ • World Health Organization Commiuce. Pediatrlct;,
:127, 1971.
~"-· Bterar. W, D., and Pa rk, B H•• Immunodeficiency
.._ in 111&11./n Amoe, B. l Ed.); Progress in lmmunoloj,ry
Academic Press, 1971.

- Jan,

lloyer. J R•• Cooper, M. D., Ciabrlelscn , A. E., a nd Ooud, R A.:
Ly mphopenic forms of congenitu l imm unologic deficiency
diseases. Medicine, 47·201. 1968.
l<ngun , B. M.. nnd Stieh m, E R.: lmmu oo lo!("ic Incompete nce.
Chicago, Vea:r Book Medica l Publishers, Inc., 197 1.
Mcrlcr, E . l Ed.): Immunoglobu lins. Biologic Aspecta and Clinical Uses. Washln~n. D.C .. National Academy of Scie nces.
1970.
Waldman, T . A .. Strober, W., a nd Blaese. R. M.: Metabolism of
Immunoglobulins. / 11 Amos, B. l Ed.>: Progress in Immunology, New York, Academic Press, 1971.
T U M OR IM M UNOLOG Y

Assoctation Fran~atse paur I •f:tude du Ca ncer: Cancer et I mmuntlk. Ann. lnst. Pasteur, / 22:589. 1972.
Cold, P.: Antigenic rcvennon tn human ca ncer. Ann. Hcv. Med .•
2:.?:85. 1971
Good , R. A.: Relalwns between immunity and mnligno.ocy.
Proc. Nat. Acad. Sci. I U.S. A. I, 69: 10<!6, 1972.
Hellstrom, L , Hells tro m, K. E .. ~ogren. H. 0 ., and Warner . G .
A. Demonstration of cell-mediated immunity to h umnn neoplasms of \'ario us immunological types. l nt J . Canc:er, 7: 1,
1971
n ellstrom , K. E.. He lls trom, I, Sjogren, H. 0 ., a nd Wurner, G .
A .. Cell-mediated immunity to human tumor antigens. In
Amos, B. !Ed.l: J>rogres~ in Immunology. New York, Academic Press, 1971.
Klein, E., and Cochran , A .J.: Immunology and ma lillllon l di scase. Haemutologta, 5: 179, 1971
Law, L. W.: Studtes of tumor tlnttgcns and tumor-sp<lCific tmmunc mechanisms in expenmental syste ms Transpl Proc ..
2:117, 1970.
McDevi tt, H 0 .. and Bodmer . W F.. Histocompottbtltty antigens, immune respoust"encsJt and susccptthihty lO disease.
A mer. J . 1\'k-d.. 52: 1. 1972
Sjtlgre n, U. 0 .. and Banl!al , S. C.: Anltgens in vlrnlly Induced
tumors. In Amos, B. l Ed.): Prowess in Immunology Now
York. Academic Pres.•. 197 J
Smith, R. T.- Potentials for immunologic int{'n·cnlion in cancer
In Amos. B. t Ed. I: Progress in Immunology New York. Acodemic Pre.o;s, 1971
Todaro, G J ., and Huebner, R. J .: The virol oncogene hy p11th·
es t&: New evidence Proc. Nat Acad. Sci. !U.S. A. I, 69:1009,
1972.

